M. Isabel Colado

3.7k total citations · 1 hit paper
34 papers, 2.9k citations indexed

About

M. Isabel Colado is a scholar working on Cellular and Molecular Neuroscience, Toxicology and Clinical Psychology. According to data from OpenAlex, M. Isabel Colado has authored 34 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Cellular and Molecular Neuroscience, 25 papers in Toxicology and 14 papers in Clinical Psychology. Recurrent topics in M. Isabel Colado's work include Neurotransmitter Receptor Influence on Behavior (26 papers), Forensic Toxicology and Drug Analysis (25 papers) and Psychedelics and Drug Studies (14 papers). M. Isabel Colado is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (26 papers), Forensic Toxicology and Drug Analysis (25 papers) and Psychedelics and Drug Studies (14 papers). M. Isabel Colado collaborates with scholars based in Spain, United Kingdom and Brazil. M. Isabel Colado's co-authors include Esther O’Shea, J.M. Elliott, Annis O. Mechan, B. Moreno Esteban, A. Richard Green, Jorge Camarero, Verónica Sánchez, A Richard Green, Jodi L. Williams and Noelia Granado and has published in prestigious journals such as The FASEB Journal, Pharmacological Reviews and Neuroscience.

In The Last Decade

M. Isabel Colado

34 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)

2003 959 citations Annis O. Mechan, J.M. Elliott et al. Pharmacological Reviews profile →

Peers

M. Isabel Colado

CMN

TOXIC

PHARM

Esther O’Shea Spain

María Isabel Colado Spain

David Pubill Spain

J.M. Elliott United Kingdom

Paul L. Prather United States

Norberto Aguirre Spain

Georgetta Vosmer United States

Srihari R. Tella United States

L S Melvin United States

Katherine L. Nicholson United States

Esther O’Shea Spain

M. Isabel Colado

2.5k ×1.3

CMN

2.4k ×1.3

TOXIC

1.7k ×1.4

1.4k ×1.4

PHARM

427 ×1.5

Citations per year, relative to M. Isabel Colado M. Isabel Colado (= 1×) peers Esther O’Shea

Countries citing papers authored by M. Isabel Colado

Since Specialization

Citations

This map shows the geographic impact of M. Isabel Colado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Isabel Colado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Isabel Colado more than expected).

Fields of papers citing papers by M. Isabel Colado

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Isabel Colado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Isabel Colado. The network helps show where M. Isabel Colado may publish in the future.

Co-authorship network of co-authors of M. Isabel Colado

This figure shows the co-authorship network connecting the top 25 collaborators of M. Isabel Colado. A scholar is included among the top collaborators of M. Isabel Colado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Isabel Colado. M. Isabel Colado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ares‐Santos, Sara, Noelia Granado, Idaira Oliva, et al.. (2011). Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiology of Disease. 45(2). 810–820. 72 indexed citations

Granado, Noelia, Esther O’Shea, Jordi Bové, et al.. (2008). Persistent MDMA‐induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice. Journal of Neurochemistry. 107(4). 1102–1112. 93 indexed citations

Gómez, Carmela, Jesús G. Briñón, Jorge Valero, et al.. (2007). Sex differences in catechol contents in the olfactory bulb of control and unilaterally deprived rats. European Journal of Neuroscience. 25(5). 1517–1528. 13 indexed citations

Izco, María, Ivanny Marchant, Isabel Escobedo, et al.. (2007). Mice with Decreased Cerebral Dopamine Function following a Neurotoxic Dose of MDMA (3,4-Methylenedioxymethamphetamine, “Ecstasy”) Exhibit Increased Ethanol Consumption and Preference. Journal of Pharmacology and Experimental Therapeutics. 322(3). 1003–1012. 21 indexed citations

Granado, Noelia, Isabel Escobedo, Esther O’Shea, M. Isabel Colado, & Rosario Moratalla. (2007). Early loss of dopaminergic terminals in striosomes after MDMA administration to mice. Synapse. 62(1). 80–84. 57 indexed citations

Gómez, Carmela, Jesús G. Briñón, M. Isabel Colado, et al.. (2006). Differential effects of unilateral olfactory deprivation on noradrenergic and cholinergic systems in the main olfactory bulb of the rat. Neuroscience. 141(4). 2117–2128. 16 indexed citations

Izco, María, Laura Orío, Esther O’Shea, & M. Isabel Colado. (2006). Binge ethanol administration enhances the MDMA-induced long-term 5-HT neurotoxicity in rat brain. Psychopharmacology. 189(4). 459–470. 35 indexed citations

Gómez, Carmela, Jesús G. Briñón, Laura Orío, et al.. (2006). Changes in the serotonergic system in the main olfactory bulb of rats unilaterally deprived from birth to adulthood. Journal of Neurochemistry. 100(4). 924–938. 15 indexed citations

Elliott, J.M., et al.. (2006). The acute and long-term neurotoxic effects of MDMA on marble burying behaviour in mice. Journal of Psychopharmacology. 20(2). 264–271. 13 indexed citations

10.

O’Shea, Esther, Isabel Escobedo, Laura Orío, et al.. (2005). Elevation of Ambient Room Temperature has Differential Effects on MDMA-Induced 5-HT and Dopamine Release in Striatum and Nucleus Accumbens of Rats. Neuropsychopharmacology. 30(7). 1312–1323. 62 indexed citations

11.

Orío, Laura, Esther O’Shea, Verónica Sánchez, et al.. (2004). 3,4‐Methylenedioxymethamphetamine increases interleukin‐1β levels and activates microglia in rat brain: studies on the relationship with acute hyperthermia and 5‐HT depletion. Journal of Neurochemistry. 89(6). 1445–1453. 62 indexed citations

12.

Sánchez, Verónica, et al.. (2004). Effect of Repeated (‘Binge’) Dosing of MDMA to Rats Housed at Normal and High Temperature on Neurotoxicdamage to Cerebral 5-Ht and Dopamine Neurones. Journal of Psychopharmacology. 18(3). 412–416. 53 indexed citations

13.

Sánchez, Verónica, Miriam Zeini, Jorge Camarero, et al.. (2003). The nNOS inhibitor, AR‐R17477AR, prevents the loss of NF68 immunoreactivity induced by methamphetamine in the mouse striatum. Journal of Neurochemistry. 85(2). 515–524. 33 indexed citations

14.

Mechan, Annis O., et al.. (2003). The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”). Pharmacological Reviews. 55(3). 463–508. 959 indexed citations breakdown →

15.

Mechan, Annis O., B. Moreno Esteban, Esther O’Shea, et al.. (2002). The pharmacology of the acute hyperthermic response that follows administration of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) to rats. British Journal of Pharmacology. 135(1). 170–180. 165 indexed citations

16.

Sánchez, Violeta Sánchez, et al.. (2001). The mechanisms involved in the long‐lasting neuroprotective effect of fluoxetine against MDMA (‘ecstasy’)‐induced degeneration of 5‐HT nerve endings in rat brain. British Journal of Pharmacology. 134(1). 46–57. 83 indexed citations

17.

Colado, M. Isabel, Jorge Camarero, Annis O. Mechan, et al.. (2001). A study of the mechanisms involved in the neurotoxic action of 3,4‐methylenedioxymethamphetamine (MDMA, ‘ecstasy’) on dopamine neurones in mouse brain. British Journal of Pharmacology. 134(8). 1711–1723. 98 indexed citations

18.

O’Shea, Esther, et al.. (2001). Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA (‘ecstasy’) on the 5-HT and dopamine concentrations in mouse brain. Neuropharmacology. 40(1). 65–74. 83 indexed citations

19.

Snape, Mike, et al.. (1994). Chlormethiazole and Dizocilpine Block the Behavioural, but Not the Neurotoxic Effects of 5,7‐Dihydroxytryptamine in Mice. Pharmacology & Toxicology. 74(1). 40–42. 7 indexed citations

20.

Baldwin, Helen A., et al.. (1993). Striatal dopamine releasein vivofollowing neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine. British Journal of Pharmacology. 108(3). 590–596. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact